AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 59 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,400,000 | -37.6% | 656,161 | -50.2% | 0.26% | -38.7% |
| Q2 2022 | $8,649,000 | +18.1% | 1,318,421 | +0.6% | 0.42% | +26.0% |
| Q1 2022 | $7,323,000 | +27.9% | 1,309,966 | +7.3% | 0.33% | +6.0% |
| Q4 2021 | $5,725,000 | -44.3% | 1,220,758 | -26.6% | 0.32% | -38.8% |
| Q3 2021 | $10,279,000 | -14.4% | 1,663,229 | -8.7% | 0.52% | +10.8% |
| Q2 2021 | $12,002,000 | – | 1,821,176 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,986,176 | $12,275,000 | 2.58% |
| Worth Venture Partners, LLC | 454,364 | $2,808,000 | 1.26% |
| Opaleye Management Inc. | 455,600 | $2,816,000 | 0.53% |
| J. Goldman & Co LP | 1,663,229 | $10,279,000 | 0.52% |
| X-Square Capital, LLC | 92,283 | $570,000 | 0.30% |
| NEA Management Company, LLC | 3,952,958 | $24,429,000 | 0.29% |
| Birchview Capital, LP | 40,000 | $247,000 | 0.17% |
| PERSONAL CFO SOLUTIONS, LLC | 23,000 | $142,000 | 0.03% |
| PURA VIDA INVESTMENTS, LLC | 147,574 | $912,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 35,232 | $218,000 | 0.02% |